$1.05
0.011.06%
At Close: -
$1.03
-0.02-2.00%
After Hours: 9:12 AM EDT
15 minutes delayed
Comments
Loading...
Oncolytics Biotech (NASDAQ:ONCY) Stock, Earnings Estimates, EPS, And Revenue
Oncolytics Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 1
EPS Estimate
$-0.070
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Oncolytics Biotech using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCY | Oncolytics Biotech | -$0.09 | -$0.07 | — | — | $0.00 | — | — | — | 08/01/2024 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.07 | -$0.08 | -$0.07 | 12.50% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.10 | -$0.11 | -$0.04 | 63.64% | $0.00 | — | $0.00 | — | 03/07/2024 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.06 | -$0.10 | -$0.10 | -4.00% | $0.00 | — | $0.00 | — | 11/03/2023 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.07 | -$0.09 | -$0.09 | 0.00% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.09 | -$0.10 | -$0.07 | 30.00% | $0.00 | — | $0.00 | — | 05/05/2023 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.11 | -$0.07 | -$0.10 | -42.86% | $0.00 | — | $0.00 | — | 03/03/2023 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.09 | -$0.08 | -$0.06 | 25.00% | $0.00 | — | $0.00 | — | 11/07/2022 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.11 | -$0.07 | -$0.07 | 0.00% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.10 | -$0.11 | -$0.09 | 18.18% | $0.00 | — | $0.00 | — | 05/05/2022 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.16 | -$0.10 | -$0.11 | -10.00% | $0.00 | — | $0.00 | — | 03/03/2022 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.12 | -$0.12 | -$0.07 | 40.83% | $0.00 | — | $0.00 | — | 11/05/2021 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.17 | — | -$0.11 | — | $0.00 | — | $0.00 | — | 08/06/2021 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.03 | — | -$0.10 | — | $0.00 | — | $0.00 | — | 05/07/2021 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.71 | — | -$0.16 | — | $0.00 | — | $0.00 | — | 03/05/2021 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.16 | — | -$0.12 | — | $0.00 | — | $0.00 | — | 11/11/2020 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.26 | — | -$0.17 | — | $0.00 | — | $0.00 | — | 08/04/2020 | Get Alert |
| ONCY | Oncolytics Biotech | $0.04 | — | -$0.03 | — | $0.00 | — | $0.00 | — | 05/08/2020 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.28 | — | -$0.71 | — | $0.00 | — | $0.00 | — | 03/05/2020 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.20 | — | -$0.16 | — | $0.00 | — | $0.00 | — | 11/12/2019 | Get Alert |
| ONCY | Oncolytics Biotech | -$0.27 | — | -$0.26 | — | $0.00 | — | $0.00 | — | 08/13/2019 | Get Alert |
Oncolytics Biotech (ONCY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.07 | $-0.08 | 12.5 % |
| Dec 2023 | 2024-03-07 | $-0.04 | $-0.11 | 63.6 % |
| Sep 2023 | 2023-11-03 | $-0.10 | $-0.10 | -4.00 % |
| Jun 2023 | 2023-08-14 | $-0.09 | $-0.09 | 0.00 % |
Oncolytics Biotech (ONCY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Oncolytics Biotech (NASDAQ:ONCY) reporting earnings?
Oncolytics Biotech (ONCY) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Oncolytics Biotech (NASDAQ:ONCY)?
The Actual EPS was $-0.07, which beat the estimate of $-0.08.
What were Oncolytics Biotech’s (NASDAQ:ONCY) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.